ALGS - Aligos Therapeutics Inc
Previous close
13.16
0 0%
Share volume: 11,174
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.16
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-02 | 2023-03-09 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-03-12 | 2024-05-07 | |
| Total revenue | 3.693 M | 4.106 M | 3.537 M | 2.723 M | 6.886 M | 3.239 M | 2.681 M | 986.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 3.693 M | 4.106 M | 3.537 M | 2.723 M | 6.886 M | 3.239 M | 2.681 M | 986.000 K | |
| 11.18% | -13.86% | -23.01% | 152.88% | -52.96% | -17.23% | -63.22% | |||
| Operating expenses | 24.086 M | 23.054 M | 26.219 M | 26.641 M | 26.027 M | 22.310 M | 28.678 M | 23.032 M | |
| Selling general and admin | 7.576 M | 5.263 M | 7.119 M | 8.506 M | 9.246 M | 6.443 M | 6.421 M | 6.666 M | |
| Research and development | 16.510 M | 17.791 M | 19.100 M | 18.135 M | 16.781 M | 15.867 M | 22.257 M | 16.366 M | |
| Total expenses | 24.086 M | 23.054 M | 26.219 M | 26.641 M | 26.027 M | 22.310 M | 28.678 M | 23.032 M | |
| -4.28% | 13.73% | 1.61% | -2.30% | -14.28% | 28.54% | -19.69% | |||
| Operating income | -20.393 M | -18.948 M | -22.682 M | -23.918 M | -19.141 M | -19.071 M | -25.997 M | -22.046 M | |
| Ebit | -20.393 M | -18.948 M | -22.682 M | -23.918 M | -19.141 M | -19.071 M | -25.997 M | -22.046 M | |
| Pretax income | -19.877 M | -18.664 M | -21.837 M | -22.916 M | -18.034 M | -18.012 M | -27.922 M | -34.839 M | |
| -6.10% | 17.00% | 4.94% | -21.30% | -0.12% | 55.02% | 24.77% | |||
| Income tax | 47.000 K | -43.000 K | 49.000 K | 39.000 K | 757.000 K | 29.000 K | -30.000 K | 24.000 K | |
| Net income basic | -19.924 M | -18.621 M | -21.886 M | -22.955 M | -18.791 M | -18.041 M | -27.892 M | -34.863 M | |
| 6.54% | -17.53% | -4.88% | 18.14% | 3.99% | -54.60% | -24.99% | |||
| Net income | -19.924 M | -18.621 M | -21.886 M | -22.955 M | -18.791 M | -18.041 M | -27.892 M | -34.863 M | |
| 6.54% | -17.53% | -4.88% | 18.14% | 3.99% | -54.60% | -24.99% |